Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Read moreChromium is a metal for the modern age with a bright future. It is one of the more durable metals...
Read moreThe Russian government has imposed temporary restrictions on enriched uranium exports to the US. Announced on November 15, the move...
Read morePerth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation...
Read moreIonic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the...
Read moreRadiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Read moreDescription During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and...
Read moreAustralian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on...
Read moreLightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at...
Read moreProvaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for...
Read moreCopyright © 2024 InvestmentInnovate.com | All Rights Reserved